Baxter International, Inc. (BAX) Will House 400 Staffers At New R&D Center In Boston
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy
AMAG Pharmaceuticals, Inc. (AMAG) Shells Out $675 Million For Women's Health Company Lumara
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC
TONIX Pharmaceuticals, Inc. (TNXP)'s Pain Drug Fails Phase 2b Study
Genentech (RHHBY)'s New Breast Cancer Drug Greatly Extends Survival Rates
FDA Says Novartis AG (NVS), Roche (RHHBY)'s Asthma Drug Xolair Raises Risk Of Heart, Brain Problems
Pfizer (PFE)'s Lung Cancer Drug Xalkori Effective In Rare Gene Trial
Merck & Co. (MRK)'s Keytruda Shows Positive Signs In Bladder Cancer Trial
Merck & Co. (MRK)'s Keytruda Extends Immune System Fight To Stomach Cancer
Ex-Elan Corporation PLC (ELN) Trio Snags Their Former Employer’s Kinase Inhibitor Program
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators
Novartis AG (NVS)'s Sandoz, Inc. Will Move Into Former Novo Nordisk A/S (NVO) Headquarters In New Jersey
Novartis AG (NVS) Oversees Distant Regions From Miami Headquarters
Novartis AG (NVS) Drug Afinitor Is First Treatment For Advanced Pancreatic NET To Provide Overall Survival Of More Than 3.5 Years In Phase 3 Trial
German Alzheimer's Drug Developer Probiodrug AG Plans Amsterdam IPO
"Cascade” Of Biotech M&A Will Transform Specialty Pharma: Cowen
Analysts Say Valeant Pharmaceuticals International (VRX)/Allergan Inc. (AGN) Deal Could Lead To Buying Spree
See All News >
//-->